Xinbang Pharmaceutical: 2021 Annual Equity Distribution Implementation Notice
Xinbang Pharmaceutical: Announcement on the progress of the sale of shares in a wholly-owned subsidiary
Xinbang Pharmaceutical: Announcement on the resale results and delisting of “17 Xinbang 01”
Xinbang Pharmaceutical: 2017 Public Issuance of Corporate Bonds to Qualified Investors (Phase I) 2020 Interest Payment Announcement
Xinbang Pharmaceutical: Announcement on the results of the “17 Xinbang 01” resale declaration
Xinbang Pharmaceutical: Third indicative announcement on the “17 Xinbang 01” coupon interest rate not adjusted and investor resale implementation measures
Xinbang Pharmaceutical: Second indicative announcement on the “17 Xinbang 01” coupon interest rate not adjusted and investor resale implementation measures
Xinbang Pharmaceutical: First indicative announcement on the “17 Xinbang 01” coupon interest rate not adjusted and investor resale implementation measures
Xinbang Pharmaceutical: First indicative announcement on the “17 Xinbang 01” coupon interest rate not adjusted and investor resale implementation measures
Xinbang Pharmaceutical: Huarong Securities Co., Ltd.'s Interim Report on the Fiduciary Management of “17 Xinbang 01” Important Matters
Xinbang Pharmaceutical: Huarong Securities Co., Ltd.'s Interim Report on the Fiduciary Management of “17 Xinbang 01” Important Matters
Xinbang Pharmaceutical: Announcement on the progress of the sale of shares in a wholly-owned subsidiary
Xinbang Pharmaceutical: New Century Ratings Announces the Company\'s Inclusion in the Rating Watch List
Xinbang Pharmaceutical: Huarong Securities Co., Ltd.\'s Interim Report on the Fiduciary Management of “17 Xinbang 01” Important Matters
Xinbang Pharmaceutical: 2017 Public Issuance of Corporate Bonds to Qualified Investors (Phase I) Tracking Rating Report
Xinbang Pharmaceutical: 2017 Public Issuance of Corporate Bonds to Qualified Investors (Phase I) Fiduciary Management Report (2019)
Xinbang Pharmaceutical: Announcement on Sale of Shares and Related Transactions in Wholly-owned Subsidiaries
Xinbang Pharmaceutical: Public Issuance of Corporate Bonds to Qualified Investors in 2017 (Phase I) 2019 Interest Payment Notice
Xinbang Pharmaceutical: Public Issuance of Corporate Bonds to Qualified Investors in 2017 (Phase I) 2018 Interest Payment Notice
Xinbang Pharmaceutical: Announcement on Approval of Registration of Medium-Term Notes
No Data